SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-009144
Filing Date
2023-06-02
Accepted
2023-06-02 20:00:57
Documents
1
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 form4-06022023_080649.html 4  
1 form4-06022023_080649.xml 4 17755
  Complete submission text file 0001415889-23-009144.txt   19107
Mailing Address C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address
Rosen Howard B (Reporting) CIK: 0001307068 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38150 | Film No.: 23990929

Mailing Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476
Business Address 1167 MASSACHUSETTS AVENUE ARLINGTON MA 02476 781-996-5252
Kala Pharmaceuticals, Inc. (Issuer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations